Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 34768838)

  • 1. Nanotechnology Frontiers in γ-Herpesviruses Treatments.
    Granato M
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphoma.
    Jiang Y; Xu D; Zhao Y; Zhang L
    PLoS One; 2008 Feb; 3(2):e1569. PubMed ID: 18253508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancers associated with human gammaherpesviruses.
    Wen KW; Wang L; Menke JR; Damania B
    FEBS J; 2022 Dec; 289(24):7631-7669. PubMed ID: 34536980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [EBV/KSHV co-infection: an effective partnership].
    Gruffat H; Manet E
    Med Sci (Paris); 2018 Jan; 34(1):79-82. PubMed ID: 29384100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma-herpesvirus neoplasia: a growing role for COX-2.
    Shelby BD; Nelson A; Morris C
    Microsc Res Tech; 2005 Nov; 68(3-4):120-9. PubMed ID: 16276519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Thymidine Kinase (ORF21) by X-Box Binding Protein 1.
    Wang V; Davis DA; Deleage C; Brands C; Choi HS; Haque M; Yarchoan R
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31801863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double the Trouble When Herpesviruses Join Hands.
    Choi UY; Park A; Jung JU
    Cell Host Microbe; 2017 Jul; 22(1):5-7. PubMed ID: 28704653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV, HHV-8)].
    Katano H
    Uirusu; 2010 Dec; 60(2):237-45. PubMed ID: 21488336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Replication Machinery of Kaposi's Sarcoma-associated Herpesvirus and Drug Discovery Research].
    Watanabe T; Fujimuro M
    Yakugaku Zasshi; 2019; 139(1):69-73. PubMed ID: 30606932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KSHV LANA and EBV LMP1 induce the expression of UCH-L1 following viral transformation.
    Bentz GL; Bheda-Malge A; Wang L; Shackelford J; Damania B; Pagano JS
    Virology; 2014 Jan; 448():293-302. PubMed ID: 24314660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression.
    McHugh D; Caduff N; Barros MHM; Rämer PC; Raykova A; Murer A; Landtwing V; Quast I; Styles CT; Spohn M; Fowotade A; Delecluse HJ; Papoudou-Bai A; Lee YM; Kim JM; Middeldorp J; Schulz TF; Cesarman E; Zbinden A; Capaul R; White RE; Allday MJ; Niedobitek G; Blackbourn DJ; Grundhoff A; Münz C
    Cell Host Microbe; 2017 Jul; 22(1):61-73.e7. PubMed ID: 28704654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-infection and co-localization of Kaposi sarcoma-associated herpesvirus and Epstein-Barr virus in HIV-associated Kaposi sarcoma: a case report.
    Julius P; Kang G; Siyumbwa S; Musumali J; Tso FY; Ngalamika O; Kaile T; Maate F; Moonga P; West JT; Angeletti P; Wood C
    Front Cell Infect Microbiol; 2023; 13():1270935. PubMed ID: 37928187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Mechanisms of Flavonoids against Tumor Gamma-Herpesviruses and Their Correlated Cancers-A Focus on EBV and KSHV Life Cycles and Carcinogenesis.
    Hassan STS; Šudomová M
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection.
    Katano H
    Adv Exp Med Biol; 2018; 1045():357-376. PubMed ID: 29896675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's Sarcoma-Associated Herpesvirus Viral Interleukin-6 Signaling Upregulates Integrin β3 Levels and Is Dependent on STAT3.
    Rivera-Soto R; Dissinger NJ; Damania B
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31801855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus.
    Steinbrück L; Gustems M; Medele S; Schulz TF; Lutter D; Hammerschmidt W
    J Virol; 2015 Jul; 89(14):7248-61. PubMed ID: 25948739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication Is Independent of Anaphase-Promoting Complex Activity.
    Elbasani E; Gramolelli S; Günther T; Gabaev I; Grundhoff A; Ojala PM
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients.
    Cesarman E
    Cancer Lett; 2011 Jun; 305(2):163-74. PubMed ID: 21493001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutual detection of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in blood and saliva of Cameroonians with and without Kaposi's sarcoma.
    Labo N; Marshall V; Miley W; Davis E; McCann B; Stolka KB; Ndom P; Hemingway-Foday JJ; Abassora M; Newton R; Smith JS; Whitby D
    Int J Cancer; 2019 Nov; 145(9):2468-2477. PubMed ID: 31265124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr Virus gH/gL and Kaposi's Sarcoma-Associated Herpesvirus gH/gL Bind to Different Sites on EphA2 To Trigger Fusion.
    Chen J; Schaller S; Jardetzky TS; Longnecker R
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32847853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.